Company Analysis

PRF Technologies Ltd. (PRFX)

Nasdaq: PRFX · Pharmaceutical Preparations · Tel Aviv · filing with the SEC since 2020
Grade3.8
◀ Past 5.3● Present 3.0▶ Future 3.4
3 est.

Who runs PRF Technologies Ltd.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Cohen-Arazi Efraim
Interim CEO. First filing Mar 2026, latest Mar 18, 2026, 0 filings in all.
Officers reporting now
4
of 7 people with a filing in the last fifteen months
Directors reporting now
3
7 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Cohen-Arazi EfraimInterim CEOMar 2026Mar 18, 2026none
Geller EhudExec Chairman of the BoardMar 2026Mar 18, 2026none
Broder EyalChief Financial OfficerMar 2026Mar 18, 2026none
Aviel SigalChief Operating OfficerMar 2026Mar 18, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Baron Ellen SdirectorMar 2026Mar 18, 2026none
Lawlor AugustinedirectorMar 2026Mar 18, 2026none
Shavit AsafdirectorMar 2026Mar 18, 2026none

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton PRFX · research, not advice